#gilead
Latest news and interesting information about gilead.
Gilead wins FDA approval for first hepatitis delta treatment
Gilead Sciences gets FDA approval for Hepcludex, the first treatment for chronic hepatitis delta virus. Shares rose over 2%.
WHO raises Ebola risk in Congo to 'very high'
WHO raises Ebola risk in DRC to 'very high' national level. 82 confirmed cases, 7 deaths reported. Experimental drug Obeldesivir used for contacts.
Trodelvy Gets EU Backing for Breast Cancer
Gilead's Trodelvy receives EU backing for triple-negative breast cancer. ASCENT-03 study shows 38% risk reduction.
Assembly Biosciences prices $100M stock offering at $26.50
Assembly Biosciences prices $100 million stock offering at $26.50 per share. Gilead Sciences among investors. Proceeds for clinical development.
Gilead comm officer sells $3.68m stock
Gilead Sciences' comm officer Johanna Mercier sold $3.68 million in stock. The company has raised dividends for 11 straight years.
Rare, untreatable Ebola strain - global emergency
WHO declares global emergency over rare, untreatable Bundibugyo Ebola strain. Outbreak spreads in Congo and Uganda, no approved vaccine or treatment.
Galapagos NV Revenue Drops 91% in Q1 2026
Galapagos NV reports 91% revenue drop in Q1 2026 but achieves net profit. Details on transformation and gamgertamig potential.
...